Skip to content
WuXi AppTec Logo White

Targeted, expertly managed carcinogenicity studies

Evaluate the risk of long-term pharmaceutical use of your candidate, including tumorigenic potential, with WuXi AppTec. Whether you’re working on an innovative small molecule or an advanced biologic drug candidate, we’ll help you fully explore and understand your carcinogenicity options to design the best testing program for your needs.

Tell us more about your compound by filling out the form on the right and one of our experts will be in touch.

0 +
Countries Supported
0 +
Safety Assessment Staff
0 +
IND/NDA Packages Submitted Globally
0 +
Safety Assessment Studies Conducted/Year
0 %
On-Time Data and Report Delivery

Full-scale safety assessment testing platform 
for on-time delivery, every time

Whether you need a four-week rodent study to support an IND filing or a two-year carcinogenicity study for an NDA, we have completed thousands of studies in our ultra-modern 645,800 square foot facility comprising 300 animal rooms.

General Toxicology

Run a full suite of GLP and non-GLP general toxicology studies, including early-stage dose range finding studies, single dose acute toxicity testing, and repeat-dose chronic toxicity studies.

Carcinogenicity

Assess for the development of non-neoplastic and neoplastic lesions in organs and organ systems to identify tumorigenic potential in animals and determine the risk of long-term pharmaceutical use in humans.

Safety Pharmacology

Quickly and accurately assess the potential for toxicity across major therapeutic areas (including CNS, cardiovascular and respiratory) with in vitro and in vivo safety pharmacology studies.

Special Toxicity

Run special toxicity studies depending on your program need, including local irritation, sensitization, phototoxicity, and ocular toxicity studies.

Genetic Toxicity

Assess the potential for induction of genetic mutations or chromosomal damage with in vitro and in vivo genetic toxicicty tests that yield high-quality data.

Development & Reproductive Toxicology

Assess the reproductive safety of your drugs, chemicals or pesticides after repeated or chronic exposure with our IND– and NDA-enabling DART studies and services for Segment I, II and III.

Your end-to-end safety assessment testing partner

WuXi AppTec’s safety assessment services are fully integrated with our comprehensive testing platform and supported by the complementary capabilities of our DMPK and bioanalytical service teams, saving you time and costs while yielding invaluable data and insights. With multidisciplinary experience, we can support the full scope of your development program, including IND and NDA submission.